drugset / Trial / NCT03386552

A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility

NCT03386552

RandomizedParallel-groupTriple-blindTreatment

Summary

The present investigation is evaluating a method for improving pregnancy outcome of couples with unexplained infertility. The method utilizes an adjuvant pre-treatment prior to insemination, that is pertubation, i.e. flushing the uterus and fallopian tubes before insemination with a specially developed solution with the aim to increase fertility. The clinical trial is a phase II double blind, randomized, controlled and multi-center trial .

Timeline

Start
2017-06-20
Primary completion
2018-05-31
Completion
2019-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.5 mg/ml

Indications